Press-release for stocks

Prices are updated after-hours

Greenlane Announces Dismissal of Class Action Suit with Prejudice
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
GNLN | $0.6848 19.91% 16.6% 1.2M

| -89.1% | O: 0.0% H: 27.15% C: 20.27%

XPO Logistics Partners with Truckers Against Trafficking to Help Combat Human Trafficking
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
XPO | News | $115.37 -3.06% -0.32% 1.4M

| -5.64% | O: -2.02% H: 1.77% C: 0.79%

CareDx Reports Preliminary Fourth Quarter and Full Year 2020 Results
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
CDNA | $8.08 -2.42% -2.48% 670K

| -90.28% | O: 0.97% H: 1.82% C: -1.04%
results

Abcam plc Half Year Trading Update
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
ABCM | $23.99 0.0% 7.4M

| 22.15% | O: 5.7% H: 3.37% C: 2.84%

Ultragenyx Reports Preliminary 2020 Revenue and 2021 Revenue Guidance for Crysvita in Ultragenyx Territories
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
RARE F | $43.38 -1.65% -1.68% 770K

| -70.71% | O: 0.16% H: 1.31% C: -6.03%
ev

Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
FOLD F | $10.35 -1.9% -1.93% 1.7M

| -55.38% | O: 0.48% H: 2.54% C: -2.45%
therapeutics

Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Pruritus in Patients with Notalgia Paresthetica
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
CARA | $0.69 -5.73% -6.07% 360K

| -95.69% | O: 0.0% H: 4.81% C: 2.63%
trial treatment phase 2

| -31.12% | O: -0.42% H: 0.84% C: -0.32%
test

Travere Therapeutics Provides Corporate Update and 2021 Outlook
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
TVTX | $5.805 -3.09% -3.19% 970K

| -77.81% | O: -0.63% H: 3.09% C: 2.35%
therapeutics

MediWound Provides Progress Update on Its EscharEx Clinical Development Program
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
MDWD | $16.94 -2.87% -2.95% 42K

| 325.37% | O: 0.49% H: 8.74% C: -4.61%
program

| -32.62% | O: 1.06% H: 0.18% C: -1.75%
disease life science parkinson anavex®2-73 anavex

ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2021
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
ALXO M | $15.72 -2.24% -2.29% 670K

| -83.15% | O: -1.23% H: 4.43% C: 1.21%
milestone

| -36.4% | O: -0.48% H: 4.12% C: 2.43%
disease milestone

Teladoc Health and Dexcom Bring CGM Technology and Personalized Insights to People with Type 2 Diabetes at No Cost
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
TDOC S | $13.18 0.3% -0.23% 4M

| -94.23% | O: -0.2% H: 0.76% C: -2.84%
diabetes

Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
PASG | $1.18 -7.09% -7.63% 120K

| -95.62% | O: 0.11% H: 3.72% C: -3.39%
liver